PICKERING GRANT 4

What Happened
Grant Pickering, a director of LeonaBio, was granted a derivative award covering 28,000 shares on April 9, 2026. The filing lists an acquisition price of $0.00 (total reported value $0) and classifies the transaction as an award/grant (derivative).

Key Details

• Transaction date: 2026-04-09; Form 4 filed: 2026-04-13 (timely — filed within two business days).
• Transaction type/code: A (Award/Grant — derivative).
• Amount: 28,000 shares (derivative securities) reported at $0.00 per share.
• Vesting: Shares subject to the option vest monthly over 24 months from the grant date, contingent on continued service (per filing footnote).
• Shares owned after the transaction: Not specified in the filing.
• No sale or cash received — this is a compensation grant, not an open-market purchase or sale.

Context
This was a compensation-related option award that vests over two years; such grants are routine for directors and do not by themselves indicate immediate buying or selling in the market. Because this is a derivative grant (options) and not an exercised-and-sold transaction, there's no immediate cash flow or change in public share count from Pickering reported here.